Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033694 · ClinicalTrials.gov registry record
The Lipid-Rich Plaque Study
A clinical trial, sponsored by Infraredx.
- Completed
- Registry status
- 1,563
- Enrollment target
NCT02033694 is a clinical trial that has completed, run by Infraredx. The registered enrollment target is 1,563 participants.
The verdict
NCT02033694 has completed, sponsored by Infraredx.
- COMPLETED
- Registry status
- 1,563 participants
- Enrollment target
Study Summary
The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of detection of these fatty plaques can predict future events. If dangerous plaques can be identified, there are many treatments already available that could be tested for their ability to prevent coronary events.
Interventions
- DEVICE NIRS-IVUS Imaging (TVC Imaging System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,563 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02033694
The ClinicalTrials.gov registry entry for NCT02033694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,563 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Infraredx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRS-IVUS Imaging (TVC Imaging System) is the first listed.
NCT02033694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02033694 about?
NCT02033694 is a clinical study titled "The Lipid-Rich Plaque Study". The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of...
What is the current status of trial NCT02033694?
This trial is currently completed. The enrollment target is 1,563 participants. The study started on 2014-02. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02033694?
The interventions under investigation include: NIRS-IVUS Imaging (TVC Imaging System) (DEVICE).
Who is sponsoring clinical trial NCT02033694?
This trial is sponsored by Infraredx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.